Why Youโ€™re Better off Buying Lottery Tickets Than Buying Shares of CannTrust (TSX:TRST)

Even if youโ€™re the gambling type, CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) is not a stock worth taking a chance on.

In September, we learned that Health Canada was suspending CannTrust Holdings Incโ€˜s (TSX:TRST)(NYSE:CTST) licence to sell cannabis. The decision wasnโ€™t a big surprise given all the scandals surrounding the company. Since that time, the stock has gone on to plummet even further in price, falling below $1.50 at writing.

The $13 that the stock traded at earlier in the year is nothing more than a distant memory at this point, and thereโ€™s little hope of any recovery happening that would get it anywhere near that valuation again.

Buying shares of CannTrust today is extremely risky given that the company will likely be unable to turn things around.

Odds of Health Canada reinstating CannTrustโ€™s license are very remote

When the scandal first broke, there was a much better possibility of CannTrust recovering from growing marijuana illegal than there is today.

The problem today is that the CannTrust scandal has attracted a lot of attention. Given just how many issues have been uncovered thus far, itโ€™s difficult to see why Health Canada would decide to give CannTrust its license back.

The biggest reason why I wouldnโ€™t bet on it is the precedent that such a decision would make. If CannTrust doesnโ€™t lose its licenses permanently over these scandals, other companies would have to do a whole lot more before losing their licences.

One company already saw its licence revoked this year, and it wasnโ€™t nearly as publicized. While we donโ€™t know all the details, thereโ€™s no reason to believe that it was worse than CannTrustโ€™s violations.

While CannTrust can change its management, the company would still have an uphill battle gaining back the trust of both customers and investors.

Barring some flaw in Health Canadaโ€™s investigation, which took more than a couple of months to complete, itโ€™s difficult to imagine that additional controls will be sufficient given the magnitude of CannTrustโ€™s scandals.

The risk is not worth the reward

Lottery tickets are a better buy at this point than CannTrust. They require a lower buy-in to secure a good return, and a CannTrust recovery isnโ€™t likely to have much better odds. Thereโ€™s a very real possibility that CannTrust could fall to $0 and that itโ€™s ultimately delisted from the TSX.

While itโ€™s not something that might happen in a few weeks or even months, itโ€™s a very real possibility that investors should be cognizant of. A company that canโ€™t operate its core business will generate minimal (if any) sales with no value for investors.

Thereโ€™s not even the promise of future growth anymore to help get investors buying the stock.

The odds of recovery arenโ€™t good, and investors would be better off buying shares in much safer stocks instead.

Should you invest $1,000 in BCE right now?

Before you buy stock in BCE, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy nowโ€ฆ and BCE wasnโ€™t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the โ€œeBay of Latin Americaโ€ at the time of our recommendation, youโ€™d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month โ€“ one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the โ€œofficialโ€ recommendation position of a Motley Fool premium service or advisor. Weโ€™re Motley! Questioning an investing thesis โ€” even one of our own โ€” helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before Itโ€™s Too Late: This Canadian Stock Wonโ€™t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more ยป

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more ยป

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent movesโ€ฆ

Read more ยป

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a goodโ€ฆ

Read more ยป

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more ยป

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid inโ€ฆ

Read more ยป

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Hereโ€™s whyโ€ฆ

Read more ยป

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more ยป